May 1, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs, an advisory body to the health minister, on April 28 recommended approval of Astellas Pharma’s Irribow (ramosetron) for use in females. A serotonin 5-HT 3 receptor antagonist, Irribow...read more